Navigation Links
Direct recording shows brain signal persists even in dreamless sleep
Date:9/30/2008

St. Louis, Sept. 30, 2008 Neuroscientists at Washington University School of Medicine in St. Louis have taken one of the first direct looks at one of the human brain's most fundamental "foundations": a brain signal that never switches off and may support many cognitive functions.

The results, appearing online this week in the Proceedings of the National Academy of Sciences, are an important step forward for efforts to outline what neuroscientists call the functional architecture of the brain. Better understanding of this architecture will aid efforts to treat brain injury and mental disorders.

Although the brain's different specialized regions can be considered as a collection of physical structures, functional architecture instead focuses on metaphorical structures formed by brain processes and interactions among different brain regions. The "foundation" highlighted in the new study is a low-frequency signal created by neuronal activity throughout the brain. This signal doesn't switch off even in dreamless sleep, possibly to help maintain basic structure and facilitate offline housekeeping activities.

"A different, more labile and higher-frequency signal known as the gamma frequency activity has been the focus of much brain research in recent years," says first author Biyu He, a graduate student. "But we found that signal loses its large-scale structure in deep sleep, while the low-frequency signal does not, suggesting that the low-frequency signal may be more fundamental."

"What we've been finding is reorienting the way we think about how the brain works," says senior author Marcus Raichle, M.D., professor of radiology, of neurology and of neurobiology. "We're starting to see the brain as being in the prediction business, with ongoing, organized carrier frequencies within the systems of the brain that keep them prepared for the work they need to do to perform mental tasks."

Neurologists have already spent
'/>"/>

Contact: Michael C. Purdy
purdym@msnotes.wustl.edu
314-286-0122
Washington University School of Medicine
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Direct Anesthetic Infusion Helps Colorectal Cancer Patients
2. AUDIO from Medialink and Commit Lozenge: Wanna Quit Smoking With Therapeutic Nicotine? Just Follow the Directions
3. National Association of Subrogation Professionals (NASP), the Largest Insurance Subrogation Association in the World - Announced Today that Leslie Wiernik has Joined the Organization as Director of Education
4. HealthInsuranceFinders.com Launches Video Contest for Young Directors
5. Arrow International Urges Shareholders To Vote for Approval of the $45.50 Teleflex Inc. Merger and for the Current Board of Directors
6. Coalition for Pulmonary Fibrosis Launches Aggressive Ad Campaign Directed at United States Congress
7. Zimmer Holdings Offer and ORTHOsoft Directors Circular Mailed to Shareholders
8. Glass Lewis Recommends Arrow Shareholders Vote on the White Proxy Card for Merger With Teleflex and for Current Board of Directors at Arrow Annual Meeting
9. STERIS Corporation Board of Directors Names Walter M. Rosebrough Jr. President and Chief Executive Officer
10. Fitness Champion Natalie Waples to be Spokesperson for Natural Nutrition International Direct Marketing Campaign
11. Nick Childs Joins Grey New York as Director of Content Development
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine News(10 mins):Health News:Pathological Gambling May Be Successfully Treated With Medications for Substance Addiction 2Health News:Landrieu, Lincoln, Stabenow, Small Business Owners Discuss Positive Impact of Health Reform on Small Businesses 2Health News:Landrieu, Lincoln, Stabenow, Small Business Owners Discuss Positive Impact of Health Reform on Small Businesses 3Health News:Friends Without A Border's First Annual Los Angeles Gala to be Held at Hollywood Roosevelt Hotel With Special Guest Performance by Robin Thicke 2Health News:Friends Without A Border's First Annual Los Angeles Gala to be Held at Hollywood Roosevelt Hotel With Special Guest Performance by Robin Thicke 3Health News:Healthcare Partners, IPA, CEO Dr. Richard Merkin, Salute Enrollees Honored for Health Care Advocacy With Members of Congress 2Health News:Healthcare Partners, IPA, CEO Dr. Richard Merkin, Salute Enrollees Honored for Health Care Advocacy With Members of Congress 3Health News:States Slash Funding for Tobacco Prevention Programs 2Health News:States Slash Funding for Tobacco Prevention Programs 3
Breaking Medicine Technology:Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 2Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 3Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 4Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 5Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 6Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 7Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 8Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 9Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 10Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 11Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 12Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 13Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 14Vivakor Announces New Acquisition Strategy 2Millstone Medical Outsourcing Appoints New Leadership of Memphis Facility 2BioVex Agrees SPA With the FDA for a Pivotal Phase III Study With OncoVEX 28GM CSF 29 in Head and Neck Cancer 14049 1BioVex Agrees SPA With the FDA for a Pivotal Phase III Study With OncoVEX 28GM CSF 29 in Head and Neck Cancer 14049 2BioVex Agrees SPA With the FDA for a Pivotal Phase III Study With OncoVEX 28GM CSF 29 in Head and Neck Cancer 14049 3BioVex Agrees SPA With the FDA for a Pivotal Phase III Study With OncoVEX 28GM CSF 29 in Head and Neck Cancer 14049 4Palatin Technologies Inc Announces PL 3994 Poster Presentation at 2009 Heart Failure Society of America Annual Meeting 57162 1Palatin Technologies Inc Announces PL 3994 Poster Presentation at 2009 Heart Failure Society of America Annual Meeting 57162 2Palatin Technologies Inc Announces PL 3994 Poster Presentation at 2009 Heart Failure Society of America Annual Meeting 57162 3CBI Hosts Life Sciences Summit on International Trade Compliance 14047 1CBI Hosts Life Sciences Summit on International Trade Compliance 14047 2